drugset

drugset / Trial / NCT01515891

Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites

NCT01515891 ↗

Phase 1 Completed 4 enrolled Bial - Portela C S.A.

NaSingle-groupOpen-labelTreatment

Summary

To determine the absorption, metabolism and excretion of BIA 9-1067.

Timeline

Start: 2009-05
Primary completion: 2009-06
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Opicapone	Small molecule	100 mg	Oral

Indications